B-cell acute lymphoblastic leukemia with +der(1)t(1;19) (p13;p13.1) arising in the setting of CALR exon 9 mutated essential thrombocythemia.
暂无分享,去创建一个
[1] J. D. Fitzpatrick,et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. , 2013, The New England journal of medicine.
[2] Steven M Holland,et al. JAKs and STATs in immunity, immunodeficiency, and cancer. , 2013, The New England journal of medicine.
[3] H. Sørensen,et al. Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study. , 2011, Blood.
[4] J. Choi,et al. der(1)t(1;19)(p13;p13.1) in two elderly patients with myeloid neoplasms: new case reports and review of the literature. , 2009, Leukemia research.
[5] D. Palli,et al. Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome–Negative Myeloproliferative Neoplasms , 2009, Cancer Epidemiology Biomarkers & Prevention.
[6] J. Tchinda,et al. Novel der(1)t(1;19) in two patients with myeloid neoplasias. , 2002, Cancer genetics and cytogenetics.
[7] A. Hagemeijer,et al. The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients , 1998, Leukemia.